QVAR

Teva sees $2.4b from respiratory operations by 2015
Globes, Israel
Sun, 11/7/10 - 11:54 am
Teva Pharmaceuticals
Ventolin HFA
ProAir HFA
QNAZE
allergic rhinitis
Flonase
QVAR